Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-21-000008

Options or other derivatives

  • Chief Compliance Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Howard Elizabeth · Chief Compliance Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-13 Grant or award : show line 1 in the form Stock Options +200,000 200,000 D
Loading xslF345X03/wf-form4_161359901972313.xml…